Ayush ministry stops Patanjali from selling, advertising purported Covid medicine

NEW DELHI, Jun 25 (Agencies): Days after a splashy launch of its claimed ayurvedic treatment for the novel coronavirus, Patanjali Ayurved Ltd. was told by the government to stop advertising or publicising any such claim due to the lack of requisite approval. The legal provisions cited in the ministry statement also indicate that Patanjali cannot sell the product as of now.
The facts and claims made by Patanjali of the efficacy of its virus medicine, branded ‘Coronil’, were not known to the Ministry of AYUSH, according to a statement by the ministry that governs ayurvedic medicines. It asked Patanjali to stop advertising and publicising claims till the issue is examined.
“In order to make this Ministry aware of the facts of the aforesaid news and verify the claims, Patanjali Ayurved Ltd. has been asked to provide at the earliest details of the name and composition of the medicines being claimed for Covid treatment; site(s)/hospital(s), where the research study was conducted for Covid-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicising such claims till the issue is duly examined. Ministry has also requested concerned State Licensing Authority of Uttarakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19.”
Earlier today, Patanjali Founder Swami Ramdev and Managing Director Acharya Balkrishna hosted a press conference claiming the consumer goods company had developed a medicine to treat Covid-19. The company claimed it had conducted trials that showed that 69 percent of Covid-19 positive cases turned negative in three days and all patients were cured in seven days. Except for these claims by the company, it is not clear which authorities had approved the medicine, if at all, and what was the clinical evidence provided for such approvals.
Patanjali has now been cautioned by the ministry that advertising such a drug, including an Ayurvedic medicine, is regulated by the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules and directives issued by the central government pursuant to the virus outbreak.

Leave a Reply

Your email address will not be published. Required fields are marked *